Literature DB >> 35925113

[Functional outcomes after radical prostatectomy in Germany-time for action!]

Ahmed Magheli1,2, Jonas Busch3,4, Stefan Hinz3,4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35925113     DOI： 10.1007/s00120-022-01905-5

Source DB:  PubMed          Journal:  Urologie        ISSN： 2731-7064


× No keyword cloud information.
  3 in total

1.  Hormonal Treatment for Nonmetastatic Disease Recurrence After Curative Treatment of Prostate Cancer: Only for a Select Few.

Authors:  Derya Tilki; Christopher P Evans
Journal:  Eur Urol       Date:  2015-12-21       Impact factor: 20.096

2.  Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.

Authors:  Peter-Paul M Willemse; Niall F Davis; Nikolaos Grivas; Fabio Zattoni; Michael Lardas; Erik Briers; Marcus G Cumberbatch; Maria De Santis; Paolo Dell'Oglio; James F Donaldson; Nicola Fossati; Giorgio Gandaglia; Silke Gillessen; Jeremy P Grummet; Ann M Henry; Matthew Liew; Steven MacLennan; Malcolm D Mason; Lisa Moris; Karin Plass; Shane O'Hanlon; Muhammad Imran Omar; Daniela E Oprea-Lager; Karl H Pang; Catherine C Paterson; Guillaume Ploussard; Olivier Rouvière; Ivo G Schoots; Derya Tilki; Roderick C N van den Bergh; Thomas Van den Broeck; Theodorus H van der Kwast; Henk G van der Poel; Thomas Wiegel; Cathy Yuhong Yuan; Philip Cornford; Nicolas Mottet; Thomas B L Lam
Journal:  Eur Urol       Date:  2021-12-31       Impact factor: 20.096

3.  A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.

Authors:  Sarah P Psutka; Roman Gulati; Michael A S Jewett; Kamel Fadaak; Antonio Finelli; Laura Legere; Todd M Morgan; Phillip M Pierorazio; Mohamad E Allaf; Jeph Herrin; Christine M Lohse; R Houston Thompson; Stephen A Boorjian; Thomas D Atwell; Grant D Schmit; Brian A Costello; Nilay D Shah; Bradley C Leibovich
Journal:  Eur Urol       Date:  2021-11-30       Impact factor: 20.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.